These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11788647)

  • 1. Associations of glucose control with insulin sensitivity and pancreatic beta-cell responsiveness in newly presenting type 2 diabetes.
    Albarrak AI; Luzio SD; Chassin LJ; Playle RA; Owens DR; Hovorka R
    J Clin Endocrinol Metab; 2002 Jan; 87(1):198-203. PubMed ID: 11788647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus.
    Hovorka R; Chassin L; Luzio SD; Playle R; Owens DR
    J Clin Endocrinol Metab; 1998 Mar; 83(3):744-50. PubMed ID: 9506719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between beta-cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting type 2 diabetes.
    Hovorka R; Albarrak A; Chassin L; Luzio SD; Playle R; Owens DR
    Diabet Med; 2001 Oct; 18(10):797-802. PubMed ID: 11678969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Chudleigh R; Roy Choudhury S; Owens DR
    Diabet Med; 2010 Mar; 27(3):266-73. PubMed ID: 20536488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes.
    Shim WS; Kim SK; Kim HJ; Kang ES; Ahn CW; Lim SK; Lee HC; Cha BS
    Eur J Endocrinol; 2006 Oct; 155(4):615-22. PubMed ID: 16990662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
    Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
    Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.
    Roy Chowdhury S; Thomas RL; Dunseath GJ; Peter R; Rees DA; North RV; Luzio SD; Owens DR
    J Clin Endocrinol Metab; 2016 Feb; 101(2):572-80. PubMed ID: 26652932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test.
    Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Pedersen M; Pedersen BK; Kirwan JP
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E822-9. PubMed ID: 25184989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
    Heise T; Mari A; DeVries JH; Urva S; Li J; Pratt EJ; Coskun T; Thomas MK; Mather KJ; Haupt A; Milicevic Z
    Lancet Diabetes Endocrinol; 2022 Jun; 10(6):418-429. PubMed ID: 35468322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content.
    Cooper MB; Tan KC; Hales CN; Betteridge DJ
    Diabet Med; 1996 Sep; 13(9):816-27. PubMed ID: 8891457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity.
    Yuan G; Zhou L; Tang J; Yang Y; Gu W; Li F; Hong J; Gu Y; Li X; Ning G; Chen M
    Diabetes Res Clin Pract; 2006 Jun; 72(3):244-50. PubMed ID: 16377022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes.
    Schernthaner G; Guerci B; Gallwitz B; Rose L; Nicolay C; Kraus P; Kazda C
    Diabetes Metab; 2010 Nov; 36(5):389-94. PubMed ID: 20598608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test.
    Rave K; Sidharta PN; Dingemanse J; Heinemann L; Roggen K
    Diabetes Technol Ther; 2010 Feb; 12(2):117-23. PubMed ID: 20105041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.
    Cretti A; Lehtovirta M; Bonora E; Brunato B; Zenti MG; Tosi F; Caputo M; Caruso B; Groop LC; Muggeo M; Bonadonna RC
    Eur J Clin Invest; 2001 May; 31(5):405-16. PubMed ID: 11380592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemoglobin A1c is not a surrogate for glucose and insulin measures for investigating the early life and childhood determinants of insulin resistance and Type 2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and Children (ALSPAC).
    Shultis WA; Leary SD; Ness AR; Scott J; Martin RM; Whincup PH; Smith GD;
    Diabet Med; 2006 Dec; 23(12):1357-63. PubMed ID: 17116188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus.
    Lin JD; Hsia TL; Wu CZ; Su CC; Ma WY; Hsieh AT; Hsieh CH; Wang K; Chu YM; Pei D
    Metabolism; 2010 Jun; 59(6):780-6. PubMed ID: 20005535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes.
    Hanefeld M; Koehler C; Hoffmann C; Wilhelm K; Kamke W; Gerstein H
    Diabet Med; 2010 Feb; 27(2):175-80. PubMed ID: 20546261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.